A healthcare artificial intelligence (AI) spin-off from the SingHealth Duke-NUS Academic Medical Centre, Enigma Health has signed separate Memorandums of Understanding with Switzerland's Roche pharmaceutical company and Singapore's ST Engineering to extend the reach of its agentic AI platform.
At the IMDA's ATX Summit, thse trategic deals was signed to accelerate clinical trial recruitment and cut costs. With ST Engineering, it will power a platform for building AI-driven healthcare apps.
The MOU will facilitate the exploration of advanced AI and digital technologies to accelerate clinical trial recruitment, improve market access and enhance business intelligence. ST Engineering will integrate the AI firm's small language model into its Agil Genie Studio platform for building and deploying AI applications.
Enigma Health, developed by clinicians and AI experts, uses small language models analyze thousands of surgeries and millions of data points with impressive speed and accuracy.
The propriority Enigma platfrom can aid Healthcare organisations in optimizing workflow, streamline data-intensive processes, and reduce costs by using , and ease a range from administrative tasks to analysing surgeries as part of clinical audits.
